We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

24 Jul 2026 - 26 Jul 2026
05 Aug 2026 - 07 Aug 2026

MIS Cryotherapy for Kidney Tumors

By HospiMedica staff writers
Posted on 05 Aug 2002
Doctors at the University of Virginia Medical Center (UVA, Richmond, USA) treated a renal cell carcinoma in the left kidney of a 64-year-old man by using cryotherapy, eliminating the need for surgery and its complications.

The minimally invasive procedure took less than 55 minutes. More...
Doctors froze the tumor with ultra-thin needles inserted directly through the skin, using cryotherapy technology. UVA radiologists used real-time ultrasound to guide the needles to their target, where a template aligned and held them in place through two freeze/thaw cycles, which completely ablated the tumor. In this procedure, doctors used the SeedNet Gold system and CryoNeedles from Galil Medical, Ltd. (Yokneam, Israel).

When a computed tomography scan showed the 2.5 cm mass on the man's left side two months ago, a partial nephrectomy seemed to be the only option. Doctors had removed the patient's left kidney over a year ago. Now, the risk of losing the remaining kidney led to the decision to use cryosurgery. Patients undergoing this procedure can leave the hospital the same day and expect recuperation in a few days, versus laparoscopic removal (one to two days in hospital and about two weeks at home) or open surgery (one week in hospital and six weeks at home), says Galil.

"Those small CryoNeedles make this type of surgery possible,” said Dr. Theodorescu, professor of urology in UVA's department of urology. "Large conventional probes would be difficult to insert percutaneously and to direct into the kidney as well as control during the freezing process.” Dr. Theodorescu also noted that patient selection is the key to success. Patients should have tumors less than 3 cm and these should be in an anatomical position that can be viewed clearly by ultrasound.


UVA >>



Related Links:
Galil
University of Virginia Medical Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Radiofrequency Generator
GX1
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.